#CreativeDisruption: Breakthrough Oncology Innovation for Start-ups & SMEs

About the Event

The Creative Disruption Forum is a high-level, interactive gathering built for executive leaders, oncology researchers, startup founders, and biotech investors.

Designed specifically to address the unique challenges faced by early-stage and growing oncology SMEs, this forum moves beyond standard industry panels. We bring together key decision-makers to challenge legacy models, explore novel therapeutic and diagnostic pipelines, and unlock new avenues for venture capital and strategic partnerships.

Set against the backdrop of ARC West London—Hammersmith’s premier ecosystem for science and innovation—this event provides an intimate platform to network with decision-makers who are actively reshaping the cancer care landscape.

Why Attend?

• Actionable Business Intelligence: Discover new approaches to IP strategy, regulatory pathways, and non-dilutive funding tailored to oncology biotechs.
• Cross-Sector Collaboration: Connect directly with pharma executives, academic pioneers, and venture capitalists actively seeking investment-ready SME partnerships.
• Cutting-Edge Research Highlights: Explore disruptive technologies—from AI-driven drug discovery to targeted immunotherapies—that are accelerating clinical pipelines.

Summary Agenda

10:00 AM – 10:30 AM | Registration & Morning Networking

Welcome coffee and informal introductions at the ARC West London Hub.

10.30 AM - 10.45 AM kick off - Introduction by Prof Tony Sedgwick and our host sponsor Deborah Spencer from ARC West London and Mariana Vashetto from CDD Vault our supporting sponsor.

10.45 AM -11.15 AM

Prof Sarah Blagden, Oxford Uni / Prenostics - on the big picture of Oncology research today, what are the exciting prospects, challenges etc

Medhi Chelbi, Biper Tx and Landmark BioVentures - exciting oncology research from the Continent

11.15-11.45 pm

Lone Friis, C-Further - an initiative between LifeArc, Cancer Research Horizons and Great Ormond Street Hospital (GOSH) - to tackle childhood cancers
Jane Spink, Prostate Cancer UK - On their impact investing, and how they support their portfolio companies

Michelle Barnard, ValiRx plc - focuses on Oncology and Women's Health

11.45 AM-12.05 PM - Refreshment and Networking Break

12.05 PM - 12.30 PM - Raffaele Fiorenza, CDD Vault - what technologies are enabling oncology researchers

12.30 PM - 1.30 PM: Boots on the Ground Speakers

Anthony O'Kane, Finn Therapeutics

Sara Roberts, Chair, BioMarx - lung cancer diagnostic - TBC

Antonio Postigo, Stratosvir

Aleck Jones, Kindling Bio

Dan Miles, Phantom Therapeutics

1.30 PM - 2.30 PM - Lunch

2:30 PM – 3:30 PM | Workshop Discussions on key talking points from earlier sessions

3:30 PM – 4:30 PM | Workshop Closing Synthesis & Expert Summary

Key takeaways and actionable strategies for sector leaders.

END

Venue Location

ARC West London

Hammersmith, London

Situated in the heart of West London’s life sciences cluster, ARC West London provides state-of-the-art laboratory space, flexible innovation hubs, and an ideal environment for scientific discovery and commercial growth.

Secure Your Place

Space is limited to ensure high-value networking and interactive discussion.

Heart of Life Science Innovation at #CreativeDisruption Forum

Each #CreativeDisruption Forum centres on open dialogue, expert insight and interactive discussions, guided by our resident thought leader, Prof. Tony Sedgwick.

This event is also being shapped with Deborah Spencer of ARC West London, who is implicitly involved with the development of content.

Participants can expect:

•⁠ ⁠Exchange ideas with peers facing similar strategic and operational issues,

•⁠ ⁠Gain practical insights from experienced founders and executives,

•⁠ ⁠Explore actionable approaches to commercialisation and growth,

•⁠ ⁠Strengthen their professional networks across the UK life sciences community.

The Forum provides a trusted environment to discuss challenges openly, share lessons learned, and explore new ways of driving innovation.

We promise that our #CreativeDisruption Forum will be like no other life sciences event or business network you have experienced. You will be walking out of the session inspired, educated and more connected.

ADMISSION FEE for Service Companies such as CROs, CDMOs, Law Firms and Patent Attorneys, Consultancy Firms = £120 - ALL-INCLUSIVE

ADMISSION FEE for Innovative Emerging Life Science Companies and Independent Consultants = £60

Investors can apply for free entry by writing to graham@biosell.co.uk.

If you want to get involved in the programme please contact Graham Combe at graham@biosell.co.uk